A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
(Q30438645)
scientific article
scientific article
Language:
other details
description | scientific article |
External Links
(P356) |
10.1038/SJ.BJC.6600446
|
(P698) |
12107836
|
(P932) |
2376102
|
(P5875) |
11270336
|
(P6179) |
1036077984
|